Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Therapeutic Drug Monitoring
69%
Cystic Fibrosis
28%
Pharmacodynamics
25%
Nanoparticle
22%
Cohort Study
21%
Tacrolimus
19%
Tobramycin
18%
Hospital Pharmacy
18%
Pharmacogenetics
16%
Metformin
16%
Non Insulin Dependent Diabetes Mellitus
15%
Drug Metabolism
13%
Pharmacokinetics
13%
Drug Interaction
13%
Ganciclovir
13%
Hemodialysis
13%
High Performance Liquid Chromatography
12%
Ethanol
12%
Pharmacotherapy
11%
Randomized Controlled Trial
10%
Midazolam
10%
HIV
10%
Infliximab
9%
Immunosuppressive Agent
9%
Disease
9%
Inflammation
9%
Clinical Trial
8%
Methotrexate
8%
Inflammatory Bowel Disease
8%
Mouse
8%
Clozapine
8%
Dapagliflozin
8%
Sulfonylurea
8%
Toxic Injury
8%
Gentamicin
8%
Tuberculostatic Agent
8%
Levofloxacin
8%
Tablet
8%
Saliva Substitute
7%
Heart Failure
7%
Bioburden
7%
Antiinfective Agent
7%
Proton Pump Inhibitor
7%
Cholestasis
7%
Esketamine
7%
Iron Deficiency
7%
Morphine
7%
Buffer
7%
Route of Administration
7%
Acetylcysteine
7%
Volume of Distribution
7%
Lamictal
7%
Creatinine
7%
Combination Therapy
7%
Infection
7%
C Reactive Protein
7%
Side Effect
6%
Drug Concentration
6%
Vancomycin
6%
Paracetamol
6%
Drug Transport
6%
Anticonvulsive Agent
6%
Liposome
6%
Gliclazide
6%
Protein Binding
6%
Cell Culture
6%
Biological Marker
6%
Prospective Cohort Study
6%
Xenobiotic Agent
6%
Hydrocortisone
6%
Glucuronide
6%
Tolerability
6%
Chronic Obstructive Lung Disease
6%
Flucloxacillin
6%
Levetiracetam
5%
Chemotherapy
5%
Pharmacokinetic Modeling
5%
Antioxidant
5%
Prevalence
5%
Drug Development
5%
Antibiotic Agent
5%
Cross-Sectional Study
5%
Capillary Electrophoresis
5%
Drug-Drug Interaction
5%
Disease Exacerbation
5%
Posaconazole
5%
Cobicistat
5%
Neuropathic Pain
5%
Treatment Resistant Depression
5%
Multi-Drug-Resistant Tuberculosis
5%
Omeprazole
5%
Opiate
5%
Acetonitrile
5%
Drug Delivery System
5%
Carbamazepine
5%
Malignant Neoplasm
5%
Narcotic Analgesic Agent
5%
Prodrug
5%
Osteosarcoma
5%
Keyphrases
Pharmacokinetics
35%
Therapeutic Drug Monitoring
32%
Kidney Transplant Recipients
32%
Health-related Quality of Life
18%
Cystic Fibrosis
15%
Biobank
14%
Netherlands
13%
Tacrolimus
13%
Metformin
13%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
12%
Nanoparticles
12%
Tobramycin
10%
Whole Blood
10%
Proton Pump Inhibitors
10%
Hemodialysis
10%
Precision-cut Liver Slices
9%
Critically Ill Patients
9%
Microfluidic Device
8%
Gentamicin
8%
Dried Blood Spots
8%
Once-daily
8%
Ganciclovir
7%
Renal Transplant Recipients
7%
Mass Spectrometry
7%
Microfluidic Channel
7%
Saliva
7%
Inflammatory Bowel Disease
7%
Clozapine
7%
Grand Rounds
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Target Attainment
7%
Graft Failure
7%
Estimated Glomerular Filtration Rate
7%
On-a-chip
7%
Iron Deficiency
7%
Dried Blood Spot Samples
6%
Plasma Concentration
6%
Prospective Cohort Study
6%
Antidepressants
6%
Transplantation
6%
Inhalation
6%
Population Pharmacokinetics
6%
Nanoparticle Uptake
6%
Flucloxacillin
6%
Metabolism
5%
Solid Organ Transplant Recipients
5%
Drug Pharmacokinetics
5%
Pregnant Women
5%
Midazolam
5%
Human Umbilical Vein Endothelial Cells (HUVECs)
5%
C-reactive Protein
5%
Tolerability
5%
Clinical Validation
5%
Lamotrigine
5%
Extracellular Vesicles
5%
Randomized Controlled Trial
5%
Postmortem Redistribution
5%
Levetiracetam
5%
Levofloxacin
5%
Neonate
5%
Restricted Sampling
5%
Anti-tuberculosis Drugs
5%
Prednisolone
5%
Antimicrobial
5%
Drug Screening
5%
On-line Coupling
5%
Clinical Application
5%
Type 2 Diabetic Patients
5%
Daily Functioning
5%
Vancomycin Pharmacokinetics
5%
ABCB1 Polymorphism
5%
Penicillin
5%
Nadroparin
5%
Microvolume
5%
Infant Exposure
5%
Breast Milk
5%
Infliximab
5%
Ketamine
5%
Linagliptin
5%
Hemodynamic Effects
5%
Randomized Double-blind Trial
5%
Medicine and Dentistry
Kidney Graft
31%
In Vitro
22%
Hospital Pharmacy
18%
Cohort Analysis
18%
Therapeutic Drug Monitoring
17%
Glycon
15%
Quality of Life
15%
Pharmacokinetics
12%
Urinary System
11%
Pharmacodynamics
11%
Gut
10%
Liver Slice
10%
Patient with Cystic Fibrosis
10%
Digestive System
10%
Bioburden
9%
Graft Failure
8%
Kidney Function
8%
Infusion
8%
Glomerular Filtration Rate
8%
Maturity Onset Diabetes of the Young
8%
Tobramycin
7%
Randomized Controlled Trial
7%
Infliximab
7%
Iron Deficiency
7%
Alcohol Consumption
7%
Drug Therapy
7%
Biological Marker
6%
Ex Vivo
6%
Prospective Cohort Study
6%
Drug Exposure
6%
Airflow
6%
Machine Perfusion
6%
Liver Tissue
5%
Nanoparticle
5%
Injury
5%
Human Immunodeficiency Virus
5%
Patient with Type 2 Diabetes
5%
Metabolomics
5%
Mass Spectrum
5%
Antibiotics
5%
Esketamine
5%
Treatment Resistant Depression
5%
Cancer Cell
5%
Hydrochlorothiazide
5%
Patient-Reported Outcome
5%
Dapagliflozin
5%
Ethyl Glucuronide
5%
Propofol
5%
Proton-Pump Inhibitor
5%
Cholestasis
5%
Patient with Inflammatory Bowel Disease
5%
Hormone Therapy
5%
Volunteer
5%